Article
Comparative Effectiveness Of Three Bevacizumab Formulations In Iris Neovascularization: A Propensity Score-Matched Equivalence Study With Pupillographıc Validation
2026-06-22
Abstract excerpt
<title>Abstract</title> <p>Purpose This study had two primary objectives: (1) to validate automated pupillography as a reliable quantitative research tool in iris neovascularization (NVI); and (2) to compare the 24-month pupillographic outcomes of three bevacizumab formulations (Altuzan, Zirabev, Mvasi) using equivalence testing in a head-to-head design. Methods Among 78 treatment-naive NVI patients, 1:1:1 prop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 527e320b-9622-535a-bbdf-c4f445442f47
- DOI
- 10.21203/rs.3.rs-9869549/v1
